This study analyzes the efficacy of Nirmatrelvir and Ritonavir (NMV-r; Paxlovid) for outpatient treatment of COVID-19 in the pediatric population in the age group 12-18 years by using real-world data from N3C. The study uses propensity matching to create a treatment cohort and a control cohort. It further analyzes the clinical outcome such as hospitalization and ED visits following infection with COVID-19.
Title
Studying the efficacy of Nirmatrelvir and Ritonavir (Paxlovid) for outpatient treatment of COVID-19 in the pediatric population using real-world data from the National COVID Cohort Collaborative (N3C)
Publisher
Oregon Health and Science University
Date
2024-06-16
Language
English
Content Type
Capstone
Degree Type
M.S.
Academic Program
Health & Clinical Informatics
Department
Department of Medical Informatics and Clinical Epidemiology
School
School of Medicine
Record ID
43401
Record Created
2024-06-15
